Next Article in Journal
Anti-Inflammatory, Antibacterial, Anti-Biofilm, and Anti-Quorum Sensing Activities of the Diterpenes Isolated from Clinopodium bolivianum
Next Article in Special Issue
A Pharmacokinetic Study of the Interaction Between Regorafenib and Paracetamol in Male Rats
Previous Article in Journal
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic–Pituitary–Thyroid Axis Activity in Women with Subclinical Hypothyroidism

by
Robert Krysiak
1,*,
Karolina Kowalcze
2,3,
Witold Szkróbka
1 and
Bogusław Okopień
1
1
Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland
2
Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland
3
Department of Pathophysiology, Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland
*
Author to whom correspondence should be addressed.
Pharmaceutics 2024, 16(8), 1093; https://doi.org/10.3390/pharmaceutics16081093
Submission received: 16 July 2024 / Revised: 8 August 2024 / Accepted: 17 August 2024 / Published: 20 August 2024

Abstract

Metformin inhibits enhanced secretion of anterior pituitary hormones. Its impact on prolactin and gonadotropin concentrations is absent in individuals with hypovitaminosis D. The aim of this prospective cohort study was to investigate whether vitamin D status determines the effect of metformin on hypothalamic–pituitary–thyroid axis activity in levothyroxine-naïve women. The study included three groups of women of reproductive age with subclinical non-autoimmune hypothyroidism, which were matched for age, thyroid-stimulating hormone (TSH) concentration, and insulin sensitivity: untreated women with vitamin D deficiency/insufficiency (group A), women effectively supplemented with exogenous calciferol (group B), and untreated women with normal 25-hydroxyvitamin D concentrations (25OHD) (group C). Owing to concomitant type 2 diabetes or prediabetes, all subjects were treated with metformin. Concentrations of 25OHD, TSH, total and free thyroid hormones, glucose, insulin, glycated hemoglobin (HbA1c), prolactin, and peripheral markers of thyroid hormone action were assayed before metformin treatment and six months later. Based on hormone concentration, structure parameters of thyroid homeostasis were calculated. Except for 25OHD concentrations, there were no between-group differences in baseline values of the measured variables. Metformin reduced glucose, the homeostatic model assessment 1 of insulin resistance ratio (HOMA1-IR), and HbA1c in all study group, but these effects were less pronounced in group A than in the remaining groups. The reduction in TSH and Jostel’s index was observed only in groups B and C, and its degree correlated with baseline TSH concentrations, baseline 25OHD concentrations, and the degree of improvement in HOMA1-IR. The drug did not affect circulating levels of 25OHD, free and total thyroid hormones, prolactin, other structure parameters of thyroid homeostasis, and markers of thyroid hormone action. The obtained results allow us to conclude that low vitamin D status in young women mitigates the impact of metformin on thyrotroph secretory function.
Keywords: insulin resistance; metformin; thyrotrope secretory function; vitamin D status; women insulin resistance; metformin; thyrotrope secretory function; vitamin D status; women

Share and Cite

MDPI and ACS Style

Krysiak, R.; Kowalcze, K.; Szkróbka, W.; Okopień, B. The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic–Pituitary–Thyroid Axis Activity in Women with Subclinical Hypothyroidism. Pharmaceutics 2024, 16, 1093. https://doi.org/10.3390/pharmaceutics16081093

AMA Style

Krysiak R, Kowalcze K, Szkróbka W, Okopień B. The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic–Pituitary–Thyroid Axis Activity in Women with Subclinical Hypothyroidism. Pharmaceutics. 2024; 16(8):1093. https://doi.org/10.3390/pharmaceutics16081093

Chicago/Turabian Style

Krysiak, Robert, Karolina Kowalcze, Witold Szkróbka, and Bogusław Okopień. 2024. "The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic–Pituitary–Thyroid Axis Activity in Women with Subclinical Hypothyroidism" Pharmaceutics 16, no. 8: 1093. https://doi.org/10.3390/pharmaceutics16081093

APA Style

Krysiak, R., Kowalcze, K., Szkróbka, W., & Okopień, B. (2024). The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic–Pituitary–Thyroid Axis Activity in Women with Subclinical Hypothyroidism. Pharmaceutics, 16(8), 1093. https://doi.org/10.3390/pharmaceutics16081093

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop